rs141656719

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong

The ENST00000397163.8(CAPN3):​c.1468C>T​(p.Arg490Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000227 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R490Q) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

CAPN3
ENST00000397163.8 missense

Scores

13
2
4

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:22

Conservation

PhyloP100: -0.0230
Variant links:
Genes affected
CAPN3 (HGNC:1480): (calpain 3) Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in ENST00000397163.8
PM5
Other missense variant is known to change same aminoacid residue: Variant chr15-42401755-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 17622.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.948
PP5
Variant 15-42401754-C-T is Pathogenic according to our data. Variant chr15-42401754-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 166790.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42401754-C-T is described in Lovd as [Pathogenic]. Variant chr15-42401754-C-T is described in Lovd as [Pathogenic]. Variant chr15-42401754-C-T is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CAPN3NM_000070.3 linkuse as main transcriptc.1468C>T p.Arg490Trp missense_variant 11/24 ENST00000397163.8 NP_000061.1
CAPN3NM_024344.2 linkuse as main transcriptc.1468C>T p.Arg490Trp missense_variant 11/23 NP_077320.1
CAPN3NM_173087.2 linkuse as main transcriptc.1324C>T p.Arg442Trp missense_variant 10/21 NP_775110.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CAPN3ENST00000397163.8 linkuse as main transcriptc.1468C>T p.Arg490Trp missense_variant 11/241 NM_000070.3 ENSP00000380349 P2P20807-1

Frequencies

GnomAD3 genomes
AF:
0.000132
AC:
20
AN:
152084
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000836
AC:
21
AN:
251162
Hom.:
0
AF XY:
0.0000737
AC XY:
10
AN XY:
135758
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000237
AC:
347
AN:
1461786
Hom.:
0
Cov.:
32
AF XY:
0.000260
AC XY:
189
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000292
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74408
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000177
Hom.:
0
Bravo
AF:
0.000128
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000107
AC:
13
EpiCase
AF:
0.000273
EpiControl
AF:
0.000296

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:22
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2A Pathogenic:8
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Pathogenic, criteria provided, single submitterclinical testingBaylor Genetics-- -
Pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterSep 10, 2021- -
Likely pathogenic, criteria provided, single submitterclinical testingCounsylDec 28, 2016- -
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 08, 2014The p.Arg490Trp variant in CAPN3 has been reported in over 35 individuals with calpainopathy (LOVD Leiden Muscular Dystrophy database) in the homozygous and compound heterozygous state. Although this variant has been identified in 0.023% (1/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs141656719), its frequency is not high enough to rule out a pathogenic role. In summary, this variant meets our criteria to be classified as pathogenic based upon common observation in diseased individuals in the compound heterozygous state (http://pcpgm.partners.org/LMM). -
Pathogenic, criteria provided, single submittercurationSIB Swiss Institute of BioinformaticsMay 31, 2018This variant is interpreted as a Pathogenic, for Muscular dystrophy, limb-girdle, type 2A, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PM3 => For recessive disorders, detected in trans with a pathogenic variant (PMID:17157502) (PMID:15221789). PS3 => Well-established functional studies show a deleterious effect (PMID:14578192,9642272). PM5 => Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 490 of the CAPN3 protein (p.Arg490Trp). This variant is present in population databases (rs141656719, gnomAD 0.03%). This missense change has been observed in individuals with autosomal recessive limb-girdle muscular dystrophy (LGMD) 2A (PMID: 7720071, 14578192, 15221789, 16372320, 16971480, 17157502, 17994539, 18055493, 18563459, 18854869, 19015733, 21204801, 25135358, 25252031, 26632398, 27055500). ClinVar contains an entry for this variant (Variation ID: 166790). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CAPN3 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CAPN3 function (PMID: 14578192, 16971480, 19226146). This variant disrupts the p.Arg409 amino acid residue in CAPN3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14578192, 15221789, 16971480, 17994539, 18563459, 21984748, 22378277). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Likely pathogenic, criteria provided, single submitterclinical testingInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin BerlinSep 22, 2022- -
not provided Pathogenic:8
Pathogenic, criteria provided, single submitterclinical testingAthena DiagnosticsJun 01, 2020The frequency of this variant in the general population is consistent with pathogenicity. Conflicting predictions of the effect on the protein. One other pathogenic or likely pathogenic variant affects the same amino acid. This variant is statistically more frequent in affected individuals than in the general population and/or healthy controls. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. Assessment of experimental evidence suggests this variant results in abnormal protein function. -
Pathogenic, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvitySep 13, 2023- -
Pathogenic, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Pathogenic, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 08, 2016- -
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 24, 2021Published functional studies demonstrate a damaging effect as R490W impairs the autocatalytic activity of the protein, slowing protein degradation as compared to controls (Fanin et al., 2003); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20635405, 16971480, 15351423, 15221789, 12461690, 9150160, 31862442, 19226146, 17157502, 17994539, 16372320, 7720071, 21204801, 22995991, 9642272, 16627476, 26632398, 27500519, 30028523, 30919934, 18055493, 27535533, 14578192, 31589614, 25214167, 32528171) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2022CAPN3: PM3:Strong, PM2, PM5, PP1, PP3 -
Autosomal recessive limb-girdle muscular dystrophy type 2A;C4748295:Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 09, 2022- -
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
CAPN3-related disorder Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 20, 2023The CAPN3 c.1468C>T variant is predicted to result in the amino acid substitution p.Arg490Trp. This variant has been repeatedly reported in the compound heterozygous or homozygous state in individuals with limb-girdle muscular dystrophy (Gene referred to as CANP3 in Richard et al. 1995. PubMed ID: 7720071; Fanin et al. 2003. PubMed ID: 14578192; Krahn et al. 2011. PubMed ID: 21204801; Savarese et al. 2014. PubMed ID: 25214167; https://databases.lovd.nl/shared/genes/CAPN3). Functional studies indicate this variant disrupts the normal autocatalytic activity (Fanin et al. 2003. PubMed ID: 14578192). This variant is reported in 0.032% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-42693952-C-T). This variant is interpreted as pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingDASAJan 05, 2022The c.1468C>T;p.(Arg490Trp) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (Clinvar ID: 166790; PMID: 25135358; 26632398; 27055500; 30028523) - PS4.The variant is present at low allele frequencies population databases (rs141656719 – gnomAD 0.001315%; ABraOM 0.000427 frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Arg490Trp) was detected in trans with a pathogenic variant (PMID: 25135358; 26632398; 27055500; 30028523) - PM3_strong. Pathogenic missense variant in this residue have been reported Clinvar ID: 17622) - PM5. The variant co-segregated with disease in multiple affected family members (PMID: 26632398) - PP1. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic. -
Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMar 26, 2024- -
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 16, 2024Variant summary: CAPN3 c.1468C>T (p.Arg490Trp) results in a non-conservative amino acid change located in the Peptidase C2, calpain, large subunit, domain III (IPR022682) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.4e-05 in 251162 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CAPN3 causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (8.4e-05 vs 0.0032), allowing no conclusion about variant significance. c.1468C>T has been reported in the literature in multiple individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (dePaula_2002, Fanin_2003). These data indicate that the variant is very likely to be associated with disease. At least one publication reports this variant affected the normal autocatalytic function (Fanin_2003). The following publications have been ascertained in the context of this evaluation (PMID: 14578192, 12461690). ClinVar contains an entry for this variant (Variation ID: 166790). Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Pathogenic
0.34
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D;.;.;D
Eigen
Benign
-0.066
Eigen_PC
Benign
-0.33
FATHMM_MKL
Benign
0.47
N
LIST_S2
Uncertain
0.97
D;D;D;D
M_CAP
Pathogenic
0.62
D
MetaRNN
Pathogenic
0.95
D;D;D;D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Pathogenic
3.5
.;H;.;H
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-7.8
.;D;D;D
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
.;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0
.;D;D;D
Vest4
0.93
MVP
0.92
MPC
0.64
ClinPred
0.92
D
GERP RS
-3.7
Varity_R
0.87
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141656719; hg19: chr15-42693952; COSMIC: COSV58826976; COSMIC: COSV58826976; API